DTaP vaccine - GSK
Alternative Names: Acelluvax DTP; Diphtheria tetanus-acellular pertussis vaccine - GSK; Pertugen™; Triacelluvax™Latest Information Update: 02 Jul 2023
At a glance
- Originator Novartis
- Class Bacterial vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Diphtheria; Pertussis; Tetanus
Most Recent Events
- 20 Apr 2006 Chiron Corporation has been acquired and merged into Novartis
- 28 May 2002 Ventiv Health France will market Chiron's vaccines product line in France
- 01 May 2000 Launched for Diphtheria in Italy (IM)